These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6155061

  • 1. Mefenamic acid therapy in dysmenorrhea.
    Budoff PW.
    Adv Prostaglandin Thromboxane Res; 1980; 8():1449-53. PubMed ID: 6155061
    [No Abstract] [Full Text] [Related]

  • 2. Mefenamic acid, ibuprofen, and dysmenorrhea.
    Smith RP, Powell JR.
    Obstet Gynecol; 1984 Jun; 63(6):867-8. PubMed ID: 6374541
    [No Abstract] [Full Text] [Related]

  • 3. Double-blind comparison of ketoprofen and mefenamic acid in the treatment of primary dysmenorrhea.
    Hébert JG, Le Morvan P, Bourgouin J.
    Clin Ther; 1986 Jun; 8(3):329-35. PubMed ID: 3521860
    [Abstract] [Full Text] [Related]

  • 4. A double-blind comparison of a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea.
    Roy S.
    Obstet Gynecol; 1983 May; 61(5):628-32. PubMed ID: 6835617
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Nimesulide in the treatment of primary dysmenorrhea. Comparative clinical evaluation with mefenamic acid and fentiazac].
    López Rosales C, Cisneros Lugo JH, Romo Enciso LJ, García Sandoval MG.
    Ginecol Obstet Mex; 1989 Jul; 57():196-201. PubMed ID: 2486951
    [Abstract] [Full Text] [Related]

  • 11. Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors.
    Dreher E, von Fischer B.
    Adv Prostaglandin Thromboxane Res; 1980 Jul; 8():1487-93. PubMed ID: 6769316
    [Abstract] [Full Text] [Related]

  • 12. Menstrual delay and dysfunctional uterine bleeding associated with antiprostaglandin therapy for dysmenorrhea.
    Halbert DR.
    J Reprod Med; 1983 Sep; 28(9):592-4. PubMed ID: 6631846
    [Abstract] [Full Text] [Related]

  • 13. Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea.
    de Mello NR, Baracat EC, Tomaz G, Bedone AJ, Camargos A, Barbosa IC, de Souza RN, Rumi DO, Martinez Alcala FO, Velasco JA, Cortes RJ.
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):667-73. PubMed ID: 15225193
    [Abstract] [Full Text] [Related]

  • 14. [Therapy of dysmenorrhea with prostaglandin synthetase inhibitors: experiences with fluproquazone].
    Kunz J, Schneider W.
    Schweiz Med Wochenschr; 1981 Sep 26; 111(39):1451-5. PubMed ID: 6794145
    [Abstract] [Full Text] [Related]

  • 15. Fenoverine vs. mefenamic acid in the treatment of primary dysmenorrhea.
    Lira-Plascencia J, Arzola-Paniagua A, Carranza-Lira S.
    Int J Gynaecol Obstet; 2006 Apr 26; 93(1):72-3. PubMed ID: 16524578
    [No Abstract] [Full Text] [Related]

  • 16. Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea.
    Anderson AB, Haynes PJ, Fraser IS, Turnbull AC.
    Lancet; 1978 Feb 18; 1(8060):345-8. PubMed ID: 75391
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.